ライフサイエンスコーパス: vena cava

1 of the site of obstruction and the inferior vena cava.

2 the opposite trend was shown in the superior vena cava.

3 femoral vein through the adjoining inferior vena cava.

4 catheter because of stenosis in the superior vena cava.

5 (n = 4) and C57BL/6 mice (n = 5), using the vena cava.

6 ruction of the iliofemoral veins or inferior vena cava.

7 ha protein in TD compared with the aorta and vena cava.

8 bcostal four chamber, and subcostal inferior vena cava.

9 part of the right lung entering the superior vena cava.

10 eric arterioles, or ligation of the inferior vena cava.

11 , the left atrial appendage and the superior vena cava.

12 s in the right ventricular apex and superior vena cava.

13 luster between the right atrium and superior vena cava.

14 luding filter migration or thrombosis of the vena cava.

15 Robin sequence, and persistent left superior vena cava.

16 isolated and severed at the junction to the vena cava.

17 terminalis, RA free wall, and right superior vena cava.

18 d inside the coronary sinus via the superior vena cava.

19 g aorta, main pulmonary artery, and superior vena cava.

20 partial ligation (stenosis) of the inferior vena cava.

21 increased thrombus frequency in the inferior vena cava.

22 pport for cannulation of the swine aorta and vena cava.

23 +/- 0.10) and descending aorta and superior vena cava (0.14 L/min +/- 0.12).

24 y artery=26, pulmonary vein=21, and superior vena cava=12).

25 ); ascending aorta, 191 (121, 261); superior vena cava, 137 (77, 197); ductus arteriosus, 187 (109, 2

26 iosus (16/47, 34%), persistent left superior vena cava (14/47, 30%), and abnormal branching of the ri

27 re (17 +/- 2%), thorax (14 +/- 2%), inferior vena cava (23 +/- 2%) and liver (23 +/- 2%) (all P </= 0

28 68); ascending aorta, 41 (29, 53); superior vena cava, 29 (15, 43); ductus arteriosus, 41 (25, 57);

29 ated abnormality followed by double superior vena cava (9.78%).

30 RP was achieved by cannulating the aorta and vena cava after death.

31 right phrenic nerve pacing from the superior vena cava, all patients underwent diaphragmatic electrom

32 comas that most commonly affect the inferior vena cava and account for 5% of all leiomyosarcomas.

33 For the superior vena cava and brachiocephalic veins, the reconstructions

34 T for PLD facilitates total hepatectomy with vena cava and caval flow preservation.

35 facts limited the evaluation of the inferior vena cava and common iliac veins near the confluence.

36 e into the left subclavian vein and superior vena cava and evaluated for up to 90 minutes.

37 native liver with narrow access to inferior vena cava and fragile venous wall may lead to venous tea

38 of the adrenal vein drainage to the inferior vena cava and hepatic vein or of the inferior phrenic ve

39 pressor treatment by evaluating the inferior vena cava and other cardiac structures.Lung ultrasound c

40 ed-chest, large-vessel anastomosis (superior vena cava and pulmonary artery [PA] or bidirectional Gle

41 vant (>3 mm) apposition between the inferior vena cava and pulmonary venous atrium (cavoatrial overla

42 ugh a region of overlap between the inferior vena cava and pulmonary venous atrium is feasible.

43 avascular balloon positioned at the superior vena cava and right atrial junction (SVC-RAJ) reduces so

44 tracer bolus dispersion in blood between the vena cava and the arterial tree was applied.

45 th a transformation that linked the superior vena cava and the coronary sinus from the CT model with

46 Similarly, the superior vena cava and the coronary sinus were also reconstructed

47 collected from the hepatic vein and superior vena cava and underwent protein profiling for a panel of

48 Tumors invading the vena cava and/or the hepatocaval confluence are indicati

49 platelet deposition in the ligated inferior vena cava, and diminished platelet activation in vitro.

50 right coronary artery (RCA) to the inferior vena cava, and from the RCA to the tricuspid valve annul

51 y of the abdomen, heart, chest, and inferior vena cava, and many variations in technique, protocols,

52 es, septal defects, persistent left superior vena cava, and patent ductus arteriosus, were present in

53 induced by flow restriction in the inferior vena cava, APP-KO mice, as well as chimeric mice with se

54 ualized unequivocally in the murine inferior vena cava as hot spots in vivo by simultaneous acquisiti

55 icle cavity, left atrial cavity, or inferior vena cava as the IDIF.

56 ation was performed from within the inferior vena cava at areas of esophageal contact.

57 re was a 17% difference in the image-derived vena cava blood activity at 60 min, compared with the ex

58 3%-100%), whereas 55% +/- 19 of the inferior vena cava blood flowed to the left PA (range, 22%-82%).

59 ntan circulation, 87% +/- 13 of the superior vena cava blood flowed to the right PA (range, 63%-100%)

60 KG-Ibeta isoform expressed equally in TD and vena cava, both being approximately 2 times higher than

61 passage of peak activity was observed in the vena cava, but the area under the curve over 2 min was s

62 in retrograde flow, greatest in the superior vena cava.(C) RSNA, 2019Online supplemental material is

63 Superior vena cava catheterization interventions between August 1

64 osity measures, pulse generator and superior vena cava coil location, and angle of lead exit from the

65 nfidence interval 0.65-0.89) or the inferior vena cava collapsibility index (area under the curve 0.6

66 us pressure (R = 0.58), whereas the inferior vena cava collapsibility index and the internal jugular

67 cators, with a significantly higher inferior vena cava collapsibility index on day 0 than nonacidotic

68 of central venous pressure than the inferior vena cava collapsibility index or the internal jugular v

69 Inferior vena cava collapsibility index was not an independent pr

70 , low stroke volume index, and high inferior vena cava collapsibility index, which improved with subs

71 or contractility and assessment of inferior vena cava collapsibility.

72 present a unique case, in which the inferior vena cava compression by a total artificial heart was in

73 ; all P < .01), particularly in the superior vena cava.ConclusionFour-dimensional flow MRI had good-t

74 re available in 65 patients, as the inferior vena cava could not be visualized in two patients.

75 Transmural pressure of the superior vena cava decreased during inspiration, whereas the tran

76 t between the right portal vein and inferior vena cava detected on postnatal ultrasound examination.

77 An inferior vena cava diameter < 2 cm predicted a central venous pre

78 pressure (< 10 mm Hg) was 0.91 for inferior vena cava diameter (95% confidence interval 0.84-0.98),

79 ransesophageal echocardiography, of inferior vena cava diameter (IVC) measured using transthoracic ec

80 0.0001), respiratory variability of inferior vena cava diameter (r = 0.42; p < 0.01), and pulse press

81 ve study, respiratory variations of superior vena cava diameter (SVC) measured using transesophageal

82 The maximal inferior vena cava diameter correlated moderately with central ve

83 venous pressure after adjusting for inferior vena cava diameter in a multiple linear regression model

84 ut vasopressor support, the maximal inferior vena cava diameter is a more robust estimate of central

85 Respiratory variation in vena cava diameter measured by ultrasound (distensibilit

86 The proximal mouse vena cava diameter was 2.54 +/- 0.30 mm.

87 to width ratio (aspect ratio), the inferior vena cava diameter, and the percent collapse of the infe

88 ntegral, respiratory variability of inferior vena cava diameter, or pulse pressure variation.

89 ment of the central isthmus (RCA to inferior vena cava distance).

90 Patients with less vena cava distensibility were not as likely to be fluid

91 The collapsibility index of the inferior vena cava during a deep standardized inspiration is a si

92 ted into the grafts through the suprahepatic vena cava during cold storage (VSOP-NO group; n=20).

93 ential expression pattern in mouse aorta vs. vena cava ECs, which cannot be explained by the differen

94 s when they become firmly embedded along the vena cava endothelium.

95 in thrombosis (A 0%, B 24%, C 76%), inferior vena cava filter (A 0%, B 31%, C 69%), and renal artery

96 Vena cava filter (VCF) placement for pulmonary embolism

97 Early prophylactic placement of a vena cava filter after major trauma did not result in a

98 Early placement of a vena cava filter did not result in a significantly lower

99 than no placement of a filter (13.9% in the vena cava filter group and 14.4% in the control group; h

100 y embolism developed in none of those in the vena cava filter group and in 5 (14.7%) in the control g

101 Among the 46 patients in the vena cava filter group and the 34 patients in the contro

102 verity were assigned to retrievable inferior vena cava filter implantation plus anticoagulation (filt

103 Insertion of a retrievable inferior vena cava filter in patients randomized to the filter gr

104 d with a significant bleeding risk, inferior vena cava filter insertion compared with anticoagulant t

105 we assessed the association between inferior vena cava filter insertion for known significant bleedin

106 surgical pulmonary embolectomy, and inferior vena cava filter insertion.

107 indication to anticoagulant agents to have a vena cava filter placed within the first 72 hours after

108 Trauma patients and inferior vena cava filter placements were excluded.

109 embolism, the use of a retrievable inferior vena cava filter plus anticoagulation compared with anti

110 Whether early placement of an inferior vena cava filter reduces the risk of pulmonary embolism

111 r thrombosis risk factors, avoiding inferior vena cava filter usage except in specified circumstances

112 The effectiveness of inferior vena cava filter use among patients with acute symptomat

113 lism (previous thromboembolism, preoperative vena cava filter, hypoventilation, pulmonary hypertensio

114 heparin (29%), dalteparin (40%), or inferior vena cava filters (20%) were not statistically different

115 Evidence that vena cava filters (VCFs) are beneficial is limited.

116 change in the society guidelines, the use of vena cava filters (VCFs) continues to rise.

117 Although retrievable inferior vena cava filters are frequently used in addition to ant

118 Limited evidence suggests that vena cava filters are only modestly efficacious for prev

119 erventions such as thrombolysis and inferior vena cava filters are reserved for limited circumstances

120 aim to define prolonged retrievable inferior vena cava filters dwell time by determining the inflecti

121 However, mechanical approaches such as vena cava filters have high complication and treatment f

122 investigate the survival effects of inferior vena cava filters in patients with venous thromboembolis

123 Patients with retrievable inferior vena cava filters in place beyond 7 months may benefit f

124 Although chronically implanted inferior vena cava filters may result in filter-related morbidity

125 inform the management of fractured inferior vena cava filters on the basis of results from a tertiar

126 l is effective in removing embedded inferior vena cava filters refractory to standard retrieval and h

127 Superior vena cava filters should be avoided.

128 Until further data emerge, thrombolysis and vena cava filters should be reserved for patients in who

129 Inferior vena cava filters were placed in 46%.

130 y impacted retrieval of retrievable inferior vena cava filters with prolonged dwell times; however, t

131 g, feeding tube placement, tracheostomy, and vena cava filters) among nursing home residents to rates

132 d efficacy of thrombolytic therapy, inferior vena cava filters, and embolectomy during pregnancy.

133 is is best reserved for severe VTE; inferior vena cava filters, ideally the retrievable variety, shou

134 growth in placement of retrievable inferior vena cava filters, retrieval rates remain low.

135 be diminished by leg compression devices or vena cava filters.

136 e flow were performed by increasing inferior vena cava flow.

137 trial fibrillation triggered from a superior vena cava focus (1 patient) adjacent to the right PN or

138 embolism (five of 23; 22%), and the inferior vena cava (four of 23; 17%).

139 t anastomosis of liver allograft to a Dacron vena cava graft can be a feasible solution if traditiona

140 ein to the level of cortisol in the inferior vena cava >= 5.

141 ing (index of collapsibility of the superior vena cava>/=36%), inotropic support (left ventricular fr

142 rombosis created by ligation of the inferior vena cava, HO-1 expression is markedly induced.

143 Following ligation of the inferior vena cava, HO-1(-/-) mice exhibited increased nuclear fa

144 Powder; n = 7) or infusion into the inferior vena cava (Humulin R; n = 6) using an algorithm to match

145 Vena cava IDIF (n = 7) was compared with the left ventri

146 after acute insulin treatment, using a mouse vena cava IDIF approach.

147 The mouse vena cava IDIF provides repeatable assessment of the blo

148 ardial glucose uptake rates (rMGU) using the vena cava IDIF were calculated at baseline (n = 8), afte

149 ne of the following severe injuries: aortic, vena cava, iliac vessels, cardiac, grade IV/V liver inju

150 alysis was systematically assessed using the vena cava image-derived blood input function (IDIF).

151 en, kidney, brain, lung, vitreous humor, and vena cava in comparison to untreated controls (P </= .05

152 increased net and peak flow in the inferior vena cava in end inspiration compared with end expiratio

153 anipulation and improve exposure of inferior vena cava in patients with massive hepatomegaly related

154 scle tissues, such as the aorta and inferior vena cava, in which Mypt1 E23 is predominately skipped.

155 orifice of superior mesenteric artery (SMA), vena cava inferior confluence (CVC), abdominal aorta bif

156 thrombosis induced by flow reduction in the vena cava inferior, we identified blood-derived high-mob

157 geometry and flow rates through the superior vena cava, inferior vena cava, left pulmonary artery, an

158 We hypothesize that inferior vena cava-inferior atrial ganglionated plexus nerve acti

159 odegradable TEVGs were implanted as inferior vena cava interposition conduits in 2 groups of C57BL/6

160 s that were surgically implanted as inferior vena cava interposition grafts in SCID/bg mice.

161 nctive therapeutic modalities (thrombolysis, vena cava interruption, venous stenting).

162 Persistent left superior vena cava is a rare but important congenital vascular an

163 Additionally, the transmural pressure of the vena cava is decreased, whereas the transmural pressure

164 us oxygen saturation (ScvO2) in the superior vena cava is predominantly determined by cardiac output,

165 Adjunctive ablation included superior vena cava isolation in 6 patients, cavotricuspid isthmus

166 l treatment of chronic occlusion of inferior vena cava (IVC) and iliocaval confluence with angioplast

167 with incidental finding of complete inferior vena cava (IVC) and obliteration.

168 ng the IPVE, and using the aorta or inferior vena cava (IVC) as the input function.

169 e inside diameters of the aorta and inferior vena cava (IVC) at the top of L2 and the bottom of L4 an

170 Failure to remove a retrievable inferior vena cava (IVC) filter can cause severe complications wi

171 after implantation of an absorbable inferior vena cava (IVC) filter in a swine model.

172 erlapping heparin and warfarin, and inferior vena cava (IVC) filter placement were not independent pr

173 e relationship between prophylactic inferior vena cava (IVC) filter use, mortality, and VTE.

174 Inferior vena cava (IVC) filters are widely used for prevention o

175 The use of inferior vena cava (IVC) filters for prevention of venous thrombo

176 The use of inferior vena cava (IVC) filters in this population has been incr

177 divided on the role of prophylactic inferior vena cava (IVC) filters to prevent PE.

178 se of anticoagulation, placement of inferior vena cava (IVC) filters, clinical outcomes, and comments

179 ecent studies concerning the use of inferior vena cava (IVC) filters.

180 lower loop reentry (LLR) around the inferior vena cava (IVC) has been described recently.

181 unseeded control) were implanted as inferior vena cava (IVC) interposition grafts in juvenile lambs.

182 Obstruction of the inferior vena cava (IVC) is infrequent, membranous obstruction of

183 ith prothrombotic propensity in the inferior vena cava (IVC) ligation model.

184 neutrophil-rich clots after partial inferior vena cava (IVC) ligation than those that formed in wild-

185 (WT) littermates underwent partial inferior vena cava (IVC) ligation to induce venous thrombosis.

186 omponents of the venous flow in the inferior vena cava (IVC) of 14 Fontan patients and 11 normal cont

187 hat 48-hour flow restriction in the inferior vena cava (IVC) results in the development of thrombi st

188 Here, using a murine DVT model of inferior vena cava (IVC) stenosis, we demonstrate that mice with

189 Inferior vena cava (IVC) thrombosis is generally a contraindicati

190 nt of chronic iliofemoral (I-F) and inferior vena cava (IVC) thrombosis.

191 er is associated with renal vein or inferior vena cava (IVC) thrombus in up to 10% of cases.

192 t has been suggested for the use of inferior vena cava (IVC) value instead of FHVP to calculate HVPG

193 ption of the hepatic segment of the inferior vena cava (IVC) were the vascular anomalies.

194 onal profile of the mouse aorta and inferior vena cava (IVC), not restricting our analysis to the end

195 Ten inferior vena cava (IVC)-SMV punctures were performed in six pigs

196 ging tumors with extension into the inferior vena cava (IVC).

197 ) and infrahepatic and suprahepatic inferior vena cava (IVC).

198 tes through the superior vena cava, inferior vena cava, left pulmonary artery, and right pulmonary ar

199 Baseline renal vein and inferior vena cava levels of inflammatory markers were measured a

200 tibility to venous thrombosis after inferior vena cava ligation at 12 or 18 months of age (P<0.05 ver

201 ysis on thrombosis were examined by inferior vena cava ligation in congenic mice with and without alp

202 Venous thrombosis was induced by inferior vena cava ligation in mice with genetic deletion of TGFb

203 decrease the theoretical risk of a positive vena cava margin or hematologic metastases.

204 tion of the mesentericoportal vein (n = 24), vena cava (n = 3), or hepatic vein (n = 3).

205 Inferior vena cava occlusion at all experimental stages (baseline

206 temporary preload reduction during inferior vena cava occlusion initially induced an expansion of LV

207 erior vena cava thrombosis, chronic inferior vena cava occlusion, and pain from retroperitoneal or bo

208 ume loop data obtained during acute inferior vena cava occlusion.

209 Venous thrombosis was induced in the vena cava of BALB/C mice, and temporal changes in T1 rel

210 vein thrombosis was induced in the inferior vena cava of male BALB/C mice.

211 nt platelet microparticles into the inferior vena cava of mice and harvested endothelial cells from t

212 delivered in 4 and 1 swine from the inferior vena cava onto a forcefully deviated esophagus.

213 Despite significant inferior vena cava or hepatic venous compression in 65%, hepatic

214 n, 18 kg) kg of whom 4 had occluded inferior vena cava or iliac veins and 2 had previous complex vasc

215 tion of a roughened catheter into either the vena cava or the aorta.

216 llate ganglia; (3) occlusion of the inferior vena cava or thoracic aorta; (4) transient ventricular i

217 vant index of collapsibility of the superior vena cava), or increased vasopressor support (right vent

218 chian ridge, crista terminalis, and superior vena cava); or arm 3, standard approach + ablation of le

219 triotomy to the inferior vena cava, superior vena cava, or tricuspid annulus or by ablating focally i

220 id resuscitation and fluid removal, superior vena cava oxygen saturation, goal-directed, coagulation,

221 ed as the lower of the superior and inferior vena cava oxygen saturations.

222 ; P=0.005), whereas persistent left superior vena cava (P=0.85), ventricular septal defect (P=0.12),

223 ocardium in late frames as compared with the vena cava (percentage injected dose per gram, ctl: 21.4+

224 Vena cava pertinent diameters were measured 15-20 mm cau

225 artial ligation of the suprahepatic inferior vena cava (pIVCL) to simulate congestive hepatopathy-ind

226 thy through partial ligation of the inferior vena cava (pIVCL).

227 t on a rare case of persistent left superior vena cava (PLSVC) with absent right superior vena cava (

228 ne subject, a congenital left-sided superior vena cava precluded right-sided capture.

229 une 2009 and September 2018 using either the vena cava preserving piggyback technique or caval replac

230 , patients had significantly higher inferior vena cava pressures (15.6 versus 13.7 mm Hg; P=0.007), b

231 hout partial-volume correction, the inferior vena cava provides a reliable and reproducible IDIF for

232 The association between vena cava reconstruction technique and stage of postoper

233 remains controversial whether the choice of vena cava reconstruction technique impacts AKI.

234 her the collapsibility index of the inferior vena cava recorded during a deep standardized inspiratio

235 computer modeling was used to determine the vena cava recovery coefficient.

236 Superior vena cava-related symptoms occur in only 50% of patients

237 e usefulness of respiratory variation in the vena cava requires confirmatory studies.

238 o the recipient abdominal aorta and inferior vena cava, respectively.

239 After catheterization of the inferior vena cava, right atrium, foramen ovale, and left atrium

240 Because vascular injury in the superior vena cava-right atrium during transvenous lead extractio

241 useful in characterizing ILA in the superior vena cava-right atrium region.

242 Aortic or superior vena cava rim deficiencies were more common in cases tha

243 vena cava (PLSVC) with absent right superior vena cava (RSVC).

244 The presented IDIF from the vena cava showed a robust determination of CMRGlc using

245 ach]; the lowest proportion was for inferior vena cava size [75%]).

246 unted for (aortic valve was 91% and inferior vena cava size was 58%).

247 (aortic valve was 96% [highest] and inferior vena cava size was 78% [lowest]) and decreased when nonv

248 A young woman with a benign superior vena cava stenosis due to a tunneled internal jugular ve

249 umor-bearing and control mice in an inferior vena cava stenosis model.

250 mice produced a thrombus 48 h after inferior vena cava stenosis whereas 90% of wild-type mice did.

251 n a restricted-flow model of murine inferior vena cava stenosis.

252 hrough at the junction of the right superior vena cava, sulcus terminalis, and RA free wall, correspo

253 n from the lateral atriotomy to the inferior vena cava, superior vena cava, or tricuspid annulus or b

254 ency of the common wall between the superior vena cava (SVC) and the right upper pulmonary vein (RUPV

255 (PV) origin, those arising from the superior vena cava (SVC) can precipitate atrial fibrillation (AF)

256 Biatrial drainage of the right superior vena cava (SVC) is a rare form of interatrial shunting t

257 PURPOSE OF REVIEW: Superior vena cava (SVC) is one of the most important nonpulmonar

258 ility of durable pulmonary vein and superior vena cava (SVC) isolation between radiofrequency ablatio

259 estigate the causes and symptoms of superior vena cava (SVC) obstruction or occlusion and report on t

260 Superior vena cava (SVC) tears are one of the most lethal complic

261 ntral veins of the thorax including superior vena cava (SVC), brachiocephalic (BCV), subclavian (SCV)

262 if they resided anywhere within the superior vena cava (SVC).

263 lt from vascular obstruction of the superior vena cava (SVC).

264 Specifically, superior vena cava syndrome may warrant radiation, chemotherapy,

265 Superior vena cava syndrome was more common in the non-cardiac su

266 ogy department with symptoms of the superior vena cava syndrome.

267 n into aorto-iliac/visceral arteries and the vena cava (temporal resolution, five images per second;

268 atlak slope was significantly higher for the vena cava than atrial IDIF (mL/g/min, ctl: 0.11+/-0.02 v

269 a principal discharge diagnosis of inferior vena cava thrombosis (International Classification of Di

270 Vena cava thrombosis can represent a surgical challenge

271 T in the treatment of patients with inferior vena cava thrombosis in the United States.

272 ombolysis (CDT) in the treatment of inferior vena cava thrombosis is unknown.

273 Among 2674 patients admitted with inferior vena cava thrombosis, 718 (26.9%) underwent CDT.

274 tions included filter-related acute inferior vena cava thrombosis, chronic inferior vena cava occlusi

275 r cardiopulmonary bypass because of extended vena cava thrombosis; in 2 patients, a simultaneous ster

276 rom the right or left lung into the inferior vena cava, through drainage into the hepatic vein, right

277 The vena cava time-activity curve is therefore a minimally i

278 lation of a balloon catheter in the inferior vena cava to identify the lower limit of cerebral autore

279 eter positioned in the retrohepatic inferior vena cava to shunt hepatic venous effluent through an ac

280 Puncture through the inferior vena cava to the pulmonary venous atrium may be an effec

281 nonsurgical crossing from a donor (superior vena cava) to a recipient (PA) vessel and endovascular s

282 Mouse inferior vena cava-to-carotid interposition isografts were comple

283 recipient's HV confluence, and in 3 cases, a vena cava triangulation was necessary; 6 MSUD grafts req

284 dex and collapsibility index of the inferior vena cava under a deep standardized inspiration using tr

285 ng recipient hepatectomy rendered the native vena cava unsalvageable.

286 esophagus was deflected toward the inferior vena cava using an esophageal deviation balloon, and abl

287 fraction, mitral regurgitation, and inferior vena cava variability) and correlated abnormalities in s

288 and recruitment of platelets to the inferior vena cava wall after DVT induction were reduced in MC-de

289 or bladder with abdominal aorta and inferior vena cava was isolated and orthotopically sutured to the

290 PVs plus empirical isolation of the superior vena cava was performed in all.

291 In addition, the donor vena cava was too short to bridge the caval defect for i

292 iced, the catheter, access vein, and cranial vena cava were dissected, removed en bloc, and fixed in

293 l four pulmonary vein antra and the superior vena cava were isolated using an ICE-guided technique.

294 he left atrium, coronary sinus, and superior vena cava were targeted for ablation.

295 All pulmonary veins, including the superior vena cava, were successfully isolated.

296 alignment defects, and interrupted inferior vena cava with azygos continuation.

297 ided gallbladder and an interrupted inferior vena cava with azygous continuation.

298 er, and the percent collapse of the inferior vena cava with inspiration (collapsibility index) by ult

299 f chronic indwelling CVC in the low superior vena cava with thrombus in situ was established after fe

300 with a flattened right lobar portal vein and vena cava without any visible active bleeding.